GW&K Investment Management LLC Sells 2,300 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

GW&K Investment Management LLC cut its holdings in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 2.9% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 77,801 shares of the medical instruments supplier's stock after selling 2,300 shares during the quarter. GW&K Investment Management LLC owned approximately 0.32% of ICU Medical worth $10,803,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in ICUI. Quarry LP increased its position in ICU Medical by 764.3% in the 4th quarter. Quarry LP now owns 242 shares of the medical instruments supplier's stock valued at $38,000 after acquiring an additional 214 shares in the last quarter. Murphy & Mullick Capital Management Corp acquired a new position in shares of ICU Medical during the fourth quarter worth approximately $52,000. Russell Investments Group Ltd. grew its stake in shares of ICU Medical by 88.8% during the fourth quarter. Russell Investments Group Ltd. now owns 638 shares of the medical instruments supplier's stock valued at $99,000 after purchasing an additional 300 shares during the last quarter. GAMMA Investing LLC increased its holdings in shares of ICU Medical by 27.2% in the first quarter. GAMMA Investing LLC now owns 716 shares of the medical instruments supplier's stock valued at $99,000 after purchasing an additional 153 shares in the last quarter. Finally, Sterling Capital Management LLC increased its holdings in shares of ICU Medical by 813.5% in the fourth quarter. Sterling Capital Management LLC now owns 676 shares of the medical instruments supplier's stock valued at $105,000 after purchasing an additional 602 shares in the last quarter. 96.10% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts have issued reports on ICUI shares. Raymond James Financial reduced their price objective on ICU Medical from $197.00 to $187.00 and set a "strong-buy" rating on the stock in a report on Friday, May 9th. Wall Street Zen upgraded ICU Medical from a "hold" rating to a "buy" rating in a research report on Sunday, May 18th. Needham & Company LLC reiterated a "hold" rating on shares of ICU Medical in a report on Tuesday, April 8th. Finally, KeyCorp lowered their price objective on ICU Medical from $209.00 to $191.00 and set an "overweight" rating for the company in a research report on Monday, April 21st. One equities research analyst has rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Buy" and an average target price of $192.67.

Insider Buying and Selling

In related news, COO Christian B. Voigtlander sold 5,556 shares of ICU Medical stock in a transaction that occurred on Wednesday, May 14th. The shares were sold at an average price of $138.65, for a total transaction of $770,339.40. Following the transaction, the chief operating officer owned 2,389 shares of the company's stock, valued at $331,234.85. This trade represents a 69.93% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Ben Sousa sold 2,000 shares of the business's stock in a transaction that occurred on Thursday, May 15th. The shares were sold at an average price of $137.36, for a total transaction of $274,720.00. Following the transaction, the insider owned 479 shares of the company's stock, valued at approximately $65,795.44. This represents a 80.68% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 36,097 shares of company stock worth $4,860,156 in the last ninety days. 1.50% of the stock is currently owned by corporate insiders.

ICU Medical Trading Up 0.5%

ICUI stock traded up $0.71 during midday trading on Friday, reaching $129.90. The company's stock had a trading volume of 109,564 shares, compared to its average volume of 223,989. The business's 50-day simple moving average is $131.18 and its 200-day simple moving average is $142.72. The company has a quick ratio of 1.52, a current ratio of 2.59 and a debt-to-equity ratio of 0.75. ICU Medical, Inc. has a 52 week low of $117.92 and a 52 week high of $196.26. The stock has a market cap of $3.20 billion, a PE ratio of -33.92 and a beta of 0.87.

ICU Medical (NASDAQ:ICUI - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The medical instruments supplier reported $1.72 earnings per share for the quarter, beating analysts' consensus estimates of $1.23 by $0.49. ICU Medical had a positive return on equity of 6.75% and a negative net margin of 3.87%. The company had revenue of $599.49 million for the quarter, compared to the consensus estimate of $574.15 million. During the same quarter in the prior year, the business posted $0.96 EPS. The firm's quarterly revenue was up 6.7% on a year-over-year basis. As a group, sell-side analysts expect that ICU Medical, Inc. will post 4.11 EPS for the current year.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.